Evidence map›Paper›PMID 39548077›Full record

ArticleBlood cancer journal2024

Impact of TP53 mutation on genetic and cellular hierarchy profile in complex karyotype AML/MDS with increased blasts.

Jinha Hwang, Ha Nui Kim, Jung Ah Kwon, Soo-Young Yoon, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Jung Yoon

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jinha HwangDepartment of Laboratory Medicine, College of Medicine, Korea University, Seoul, South Korea.
Ha Nui KimDepartment of Laboratory Medicine, College of Medicine, Korea University, Seoul, South Korea.
Jung Ah KwonDepartment of Laboratory Medicine, College of Medicine, Korea University, Seoul, South Korea.
Soo-Young YoonDepartment of Laboratory Medicine, College of Medicine, Korea University, Seoul, South Korea.ORCID http://orcid.org/0000-0002-2302-3825
Min Ji JeonDivision of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.
Eun Sang YuDivision of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.
Dae Sik KimDivision of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.
Chul Won ChoiDivision of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.
Jung YoonDepartment of Laboratory Medicine, College of Medicine, Korea University, Seoul, South Korea. unoaotro@korea.ac.kr.ORCID http://orcid.org/0000-0001-9296-5085

Funding

National Research Foundation of Korea (NRF) 2022R1G1A1007629
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39548077
PMCPMC11568287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.